Long Daniel D.
- SEC CIK
- 0002040349
In the past year, 5 open-market sale filings worth $951.3K and no purchases.
Current role at each company
- SEPN Septerna, Inc.SVP, Drug Discoveryas of Sep 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $951.3K
- 5 filings
- Net
- −$951.3K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Long Daniel D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 (view filing)7:01 PM ET | Sep 1 | 2 days | Long Daniel D.SVP, Drug Discovery | SSale | −3.33K | $37.83 | −$126.1K | −3.3%96.4K after | 10b5-1 |
| Aug 5, 2026 (view filing)7:00 PM ET | Aug 3 | 2 days | Long Daniel D.SVP, Drug Discovery | SSale | −3.33K | $34.47 | −$114.9K | −3.3%96.4K after | 2 lots10b5-1 |
| Jul 2, 2026 (view filing)7:00 PM ET | Jul 1 | 1 day | Long Daniel D.SVP, Drug Discovery | SSale | −3.33K | $34.36 | −$114.5K | −3.3%96.4K after | 2 lots10b5-1 |
| Jun 24, 2026 (view filing) | Jun 22 | 2 days | Long Daniel D.SVP, Drug Discovery | SSale | −15.0K | $35.51 | −$532.6K | −13.5%96.4K after | 2 lots10b5-1 |
| Nov 13, 2025 (view filing) | Nov 10 | 3 days | Long Daniel D.SVP, Drug Discovery | SSale | −3.50K | $18.06 | −$63.2K | −3.6%92.9K after |